Health Dictionary Find a Doctor

Basal cell carcinoma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2] Saarah T. Alkhairy, M.D.

Overview

It is a slow-growing locally invasive lesion with an unlikely risk of metastasis. Most patients are often asymptomatic. The major complication is its recurrence and involvement of surrounding structures. With appropriate treatment, the prognosis is usually excellent.

Natural History

Complications

Prognosis

References

  1. Wong CS, Strange RC, Lear JT (October 2003). “Basal cell carcinoma”. BMJ. 327 (7418): 794–8. doi:10.1136/bmj.327.7418.794. PMC 214105. PMID 14525881.
  2. Wortsman, X.; Vergara, P.; Castro, A.; Saavedra, D.; Bobadilla, F.; Sazunic, I.; Zemelman, V.; Wortsman, J. (2015). “Ultrasound as predictor of histologic subtypes linked to recurrence in basal cell carcinoma of the skin”. Journal of the European Academy of Dermatology and Venereology. 29 (4): 702–707. doi:10.1111/jdv.12660. ISSN 0926-9959.
  3. Jebodhsingh KN, Calafati J, Farrokhyar F, Harvey JT (April 2012). “Recurrence rates of basal cell carcinoma of the periocular skin: what to do with patients who have positive margins after resection”. Can. J. Ophthalmol. 47 (2): 181–4. doi:10.1016/j.jcjo.2012.01.024. PMID 22560426.
  4. Czarnecki, D. (1998). “The prognosis of patients with basal and squamous cell carcinoma of the skin”. International Journal of Dermatology. 37 (9): 656–658. doi:10.1046/j.1365-4362.1998.00559.x. ISSN 0011-9059.
  5. Correia de Sá TR, Silva R, Lopes JM (November 2015). “Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management”. Future Oncol. 11 (22): 3023–38. doi:10.2217/fon.15.245. PMID 26449265.


Template:WikiDoc Sources

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH